NCT07931703: Safety, Tolerability and Efficacy of RGH-202 in Social Anxiety Disorder (STAGE)
- State
- Not started
- Phase
- Phase 2
- People
- 156 planned
- Started
- 12 Nov 2026
- Primary completion
- 13 Feb 2028
- Arms
- Group receiving RGH-202
- Results
- None posted
- 12 Nov 2026: Trial registered